BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

356 related articles for article (PubMed ID: 9867193)

  • 1. Utility of third generation thyrotropin assays in thyroid function testing.
    Saller B; Broda N; Heydarian R; Görges R; Mann K
    Exp Clin Endocrinol Diabetes; 1998; 106 Suppl 4():S29-33. PubMed ID: 9867193
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparison between TRH-stimulated TSH and basal TSH measurement by a commercial immunoradiometric assay in the management of thyroid disease.
    De Rosa G; Testa A; Giacomini D; Carrozza C; Maussier ML; Valenza V; D'Errico GF
    Q J Nucl Med; 1996 Jun; 40(2):182-7. PubMed ID: 8909104
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Can immunoradiometric measurement of thyrotropin (TSH) in human serum compete with a luminometric assay?].
    Zöphel K; Pinkert J; Wunderlich G; Grüning T; Franke WG
    Nuklearmedizin; 1999; 38(5):150-5. PubMed ID: 10488482
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison of the analytical and clinical performances of three thyrotropin immunoassay kits.
    Minebois-Villégas A; Rohmer V; Rachédi F; Berrut G; Boux de Casson-Raimbeau F; Wion-Barbot N; Bigorgne JC; Jallet P
    Ann Biol Clin (Paris); 1995; 53(7-8):413-8. PubMed ID: 8597312
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evaluation of thyrotropin secretion before and after TRH by third generation chemiluminescent assay. Assessment of subclinical hyperthyroidism.
    Duntas L; Grab BM; Dominguez-Munoz JE; Nelson DK; Loos U; Keck FS
    Horm Metab Res; 1993 Aug; 25(8):430-3. PubMed ID: 8225188
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Clinical value of a sensitive TSH-RIA].
    Seidel C; Ziegelitz D; Weber A; Dittmer T; Gerl H; Knappe G; Correns HJ
    Endokrinologie; 1982 Oct; 80(2):181-93. PubMed ID: 6819129
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical experience with sensitive thyrotropin measurements: diagnostic and therapeutic implications.
    Bayer MF; Kriss JP; McDougall IR
    J Nucl Med; 1985 Nov; 26(11):1248-56. PubMed ID: 3840528
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [The interpretation of the thyroid stimulating hormone (TSH) assay].
    Wiersinga WM
    Ned Tijdschr Geneeskd; 2003 Jun; 147(24):1156-8. PubMed ID: 12845833
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison of second and third generation methods for measurement of serum thyrotropin in patients with overt hyperthyroidism, patients receiving thyroxine therapy, and those with nonthyroidal illness.
    Franklyn JA; Black EG; Betteridge J; Sheppard MC
    J Clin Endocrinol Metab; 1994 Jun; 78(6):1368-71. PubMed ID: 8200938
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Low but detectable serum thyroid-stimulating hormone concentrations in ambulant subjects not receiving thyroxine.
    Chatterjee S; O'Malley BP; Price DE; Fielding AM; Aitken R
    Ann Clin Biochem; 2003 Nov; 40(Pt 6):639-42. PubMed ID: 14629801
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prevalence of abnormal thyrotropin concentrations measured by a sensitive assay in patients with type 2 diabetes mellitus.
    Celani MF; Bonati ME; Stucci N
    Diabetes Res; 1994; 27(1):15-25. PubMed ID: 7648793
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Elecsys TSH, FT4, T4, T-uptake, FT3 and T3. Clinical results of a multicentre study.
    Ebert C; Bieglmayer C; Igari J; Chan D; Torralba A; Müller C; Veys A; Bätz O; Dageförde S; Roth HJ; Neumeier D; Assmann G; Banfi GM; Yvert JP
    Wien Klin Wochenschr; 1998; 110 Suppl 3():27-40. PubMed ID: 9677670
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Contemporary approach to thyroid disease emphasizing use of high-sensitivity thyrotropin assays.
    Feldkamp CS; McKenna MJ
    Henry Ford Hosp Med J; 1991; 39(1):25-9. PubMed ID: 1856097
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Current TSH-sensitive assays simplify thyroid diagnosis].
    Gerber H; Peter HJ; Koechli HP
    Schweiz Med Wochenschr; 1987 Oct; 117(41):1565-70. PubMed ID: 3313695
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Thyroglobulin measurement. Techniques, clinical benefits, and pitfalls.
    Spencer CA; Wang CC
    Endocrinol Metab Clin North Am; 1995 Dec; 24(4):841-63. PubMed ID: 8608781
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Evaluation of TSH suppression using a 3d-generation TSH assay: diagnostic and therapeutic consequences].
    Exer P; Staub JJ; Zulewski H; Müller B; Kunz M; Huber P
    Schweiz Med Wochenschr; 1992 Dec; 122(51-52):1964-7. PubMed ID: 1475661
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical application of free thyroxine determinations.
    Kaptein EM
    Clin Lab Med; 1993 Sep; 13(3):653-72. PubMed ID: 8222580
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Applications of a new chemiluminometric thyrotropin assay to subnormal measurement.
    Spencer CA; LoPresti JS; Patel A; Guttler RB; Eigen A; Shen D; Gray D; Nicoloff JT
    J Clin Endocrinol Metab; 1990 Feb; 70(2):453-60. PubMed ID: 2105333
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Two sensitive immunometric assays for serum thyroid stimulating hormone evaluated.
    Papadea C; Papadea NA; Cate JC; Didyk RB
    Ann Clin Lab Sci; 1998; 28(2):88-98. PubMed ID: 9558447
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Measurement of thyrotropin in clinical and subclinical hyperthyroidism using a new chemiluminescent assay.
    Ross DS; Ardisson LJ; Meskell MJ
    J Clin Endocrinol Metab; 1989 Sep; 69(3):684-8. PubMed ID: 2760176
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.